Beiersdorf’s growth outlook looks tough to achieve, says RBC

RBC Capital Markets projects Beiersdorf (ETR:BEIG) will likely miss its full-year organic sales growth guidance, forecasting 2025 growth at 3.9% (92bps below consensus) due to an "unrealistically challenging" second-half, intensifying competition, and Nivea's market share decline in key regions. The firm also cut EBIT margin forecasts, citing increased marketing spend and headwinds for high-margin brands like La Prairie, leading to a 2027 adjusted EBIT forecast 9% below consensus. Despite maintaining a "Sector Perform" rating given the stock's underperformance and reasonable 2026E EV/NOPAT of 17x, RBC lowered its price target to €107 from €120, cautioning against any reduction in marketing spend that could harm long-term growth.

Analysis

RBC Capital Markets has issued a notably bearish outlook on Beiersdorf, projecting the company will miss its full-year organic sales growth guidance of 4-6%, which it deems "unrealistically challenging." This assessment is anchored in a volatile consumer environment and intensifying competition, leading RBC to forecast 2025 organic sales growth of just 3.9%, a significant 92 basis points below consensus. The core Nivea brand is identified as a key area of weakness, with documented market share declines in the critical U.S., China, and Germany markets. RBC expresses skepticism that upcoming premium launches, such as Epicelline, can reverse this trend, citing risks of cannibalizing the existing Q10 range and potential consumer price sensitivity. Profitability is also under pressure; EBIT margin forecasts have been reduced due to expected increases in marketing spend, with RBC’s 2027 adjusted EBIT forecast now standing 9% below consensus. Further headwinds affect the high-margin La Prairie brand, where extreme pricing is hampering demand. Despite these fundamental challenges, RBC maintains a "Sector Perform" rating, a decision primarily justified by the stock's significant year-to-date underperformance of approximately 20% against peers and a valuation deemed reasonable at a 2026E EV/NOPAT multiple of 17x. This rationale is coupled with a lowered 12-month price target of €107, down from €120.

Key Decisions for Investors

• Investors should temper near-term growth expectations, as Beiersdorf's official 4-6% organic sales guidance is now considered highly improbable by analysts due to competitive and consumer pressures.
• Closely monitor market share data for the core Nivea brand, particularly in key geographies, as a failure to stabilize or reverse recent declines would validate the pessimistic outlook on revenue.
• While the stock's recent underperformance may offer a valuation cushion, consider holding off on new positions until there is evidence of a successful product launch cycle or a recovery in the high-margin La Prairie segment.
• Pay close attention to management's strategy regarding marketing expenditure, as any reduction in spend to protect short-term profitability could signal deeper issues and jeopardize long-term brand health and growth.